Addeo A

Role of KRAS in NSCLC: present and future

• Addeo A
• Bini R

Lung cancer is the leading cause of cancer-related deaths worldwide. Despite therapeutic advances over the last several decades, the overall 5-year survival remains only 16%. (Siegel R, 2013). Molecular studies have indicated that Adenocarcinomas have distinct genomic alterations allowing classification into clinically relevant molecular subsets. Such specific molec.. Read More»

Genet. Mol. Res. 17(1): gmr16039873

DOI: 10.4238/gmr16039873